Oral Wegovy (Semaglutide Pill) Approved by the FDA in December 2025, Oral Wegovy offers the benefits of GLP-1 science in a pill form, making it an attractive option for those who prefer not to deal with injections
As one of the brains most important neurotransmitters, acetylcholine is essential for learning, memory, and cognitive function
However, research shows that it due to the short half-life of this medication which can be between 2 to 10 minutes (vs 36 hours for hCG), injections a minimum of 6 times daily are needed have a similar clinical effect as two 500iu injections of hCG Once taken, a single dose may be in a patients system and effective from anywhere between 36-72 hours depending on the individual patient, their reaction to the medication and the dose/amount of medication taken
A massive July 2025 survey published in the Proceedings of the National Academy of Sciences (PNAS) analyzed treatment efficacy for thousands of patients with Long COVID and ME/CFS
This hypothesis was confirmed by several studies that had reported an important correlation between GSH levels and its positive effect on the active vitamin D ratio in the body where they showed that GSH deficiency is associated with increased oxidative stress where they epigenetically alter vitamin D regulatory genes and, as a result, the suppressed gene expression decreases vitamin D biosynthesis, ultimately leading to a secondary deficiency of vitamin D3